A major risk factor for the development of coronary heart disease (CHD) or atherosclerosis is elevated levels of serum cholesterol. Recent clinical trials and studies have confirmed that lowering of low-density lipoprotein (LDL) cholesterol is related to a reduction in CHD risk.2,3) The reduction of serum cholesterol levels has mainly been accomplished by inhibiting cholesterol biosynthesis or by blocking the absorption of dietary cholesterol. Statins, such as pravastatin, that effectively inhibit cholesterol biosynthesis are HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase) inhibitors and are widely prescribed in the treatment of hypercholesterolemia. 4,5) Several squalene synthesis inhibitors have been also reported.6,7) SCH-48461 (a trans-azetidinone) 8) and 4Љ,6Љ-bis((2-fluorophenyl)carbamoyl) b-O-cellobioside (a steriodal glycoside) 9) have recently been reported to be cholesterol absorption inhibitors.Phytosterols, or plant sterols, are an interesting class of compound due to their application and biological activities. The phytosterols found most frequently in nature are b-sitosterol, campesterol, and stigmasterol. It has been known that they inhibit the absorption of dietary and endogenously produced cholesterol from the small intestine, reducing blood cholesterol concentrations both in animal models and in humans.10-13) b-Sitosterol and b-sitostanol fatty acid esters were recently commercialized as food additives to reduce serum cholesterol levels. A novel hydrophilic phytostanol analogue, FM-VP4, was also developed to reduce serum cholesterol levels.
14)However, even with the current therapeutic agents, it is not easy to achieve proper plasma cholesterol levels without side effect. Therefore the discovery of more effective, well-tolerated agents that reduce high cholesterol levels is needed. We here report the synthesis and interesting pharmacologic properties of novel succinamic acid ester derivatives that are bsitosterol analogues, compounds 1 and 2, that have the ability to lower plasma cholesterol levels and that can be more effective cholesterol-lowering alternatives to b-sitosterol and bsitostanol fatty acid esters.
ChemistryThe synthesis of b-sitosterol analogues 1 and 2 are summarized Chart 1. The b-sitosterol-3-hemisuccinate ester 1 was prepared by the reaction of b-sitosterol and succinic anhydride in toluene with a catalytic amount of DMAP.15) The chlorination of the resulting acid compound 1 with SOCl 2 and then direct amination with appropriate amines afforded N-substituted succinamic acid b-sitosteryl ester derivatives 2. Compounds 2 were also synthesized in 76-92% yields by the reaction of 1 with methyl chloroformate, followed by amination of the activated intermediate. Interestingly, compound 2a (DANA87) was also easily obtained in one step by the direct addition of b-sitosterol to dicyclohexylcarbodiimide (DCC) in 80% yield. It was considered that compound DANA87 was prepared by slow thermal degradation of the N-Substituted succinamic acid b b-sitosteryl ester derivat...